{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:13:30Z","timestamp":1790356410660,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005915","name":"Tata Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bbrc.2022.12.023","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T03:34:17Z","timestamp":1670470457000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Sofosbuvir and its tri-phosphate metabolite inhibit the RNA-dependent RNA polymerase activity of non-structural protein 5 from the Kyasanur forest disease virus"],"prefix":"10.1016","volume":"641","author":[{"given":"Mansi","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathy","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-0350","authenticated-orcid":false,"given":"Anirudha","family":"Lakshminarasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.12.023_bib1","first-page":"619","article-title":"Kyasanur forest disease III. A preliminary report on the nature of the infection and clinical manifestations in human beings","volume":"11","author":"Work","year":"1957","journal-title":"Indian J. Med. Sci."},{"key":"10.1016\/j.bbrc.2022.12.023_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.1-61.v1","article-title":"Kyasanur forest disease virus: viremia and challenge studies in monkeys with evidence of cross-protection by Langat virus infection","volume":"1","author":"Shah","year":"2012","journal-title":"F1000Research"},{"key":"10.1016\/j.bbrc.2022.12.023_bib3","series-title":"Wildlife Arthropods of Karnataka with Special Reference to KFD Endemic Area of Shivamogga District: Those Parasitic on Small and Large Mammals","author":"Muraleedharan","year":"2016"},{"key":"10.1016\/j.bbrc.2022.12.023_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(60)90024-9","article-title":"Studies on the transmission of Kyasanur Forest disease virus by Haemaphysalis spinigera newman","volume":"54","author":"Varma","year":"1960","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2022.12.023_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/ijmr.IJMR_688_17","article-title":"Clinical & epidemiological significance of Kyasanur forest disease","volume":"148","author":"Munivenkatappa","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbrc.2022.12.023_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijid.2021.05.036","article-title":"Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease","volume":"108","author":"Majumdar","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002025","article-title":"Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, south India, 2005\u201310","volume":"7","author":"Kasabi","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001352","article-title":"Ancient ancestry of KFDV and AHFV revealed by complete genome analyses of viruses isolated from ticks and mammalian hosts","volume":"5","author":"Dodd","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib10","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/microorganisms8091406","article-title":"Kyasanur forest disease and Alkhurma hemorrhagic fever virus\u2014two neglected zoonotic pathogens","volume":"8","author":"Bhatia","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbrc.2022.12.023_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0042-6822(03)00246-0","article-title":"Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus","volume":"313","author":"Lin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2022.12.023_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1502.080979","article-title":"Isolation of Kyasanur forest disease virus from febrile patient, yunnan, China","volume":"15","author":"Wang","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-75-1-227","article-title":"Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex","volume":"75","author":"Venugopal","year":"1994","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib14","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.3390\/ijms160612943","article-title":"A\u00a0structural overview of RNA-dependent RNA polymerases from the Flaviviridae family","volume":"16","author":"Wu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.12.023_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1099\/vir.0.062208-0","article-title":"Flavivirus RNA methylation","volume":"95","author":"Dong","year":"2014","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib16","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1128\/JVI.79.18.11555-11558.2005","article-title":"Adaptive value of high mutation rates of RNA viruses: separating causes from consequences","volume":"79","author":"Elena","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coviro.2021.07.001","article-title":"Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses","volume":"50","author":"Fernandes","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jphs.2018.06.012","article-title":"Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection","volume":"138","author":"Yao","year":"2018","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2022.12.023_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01130-20","article-title":"Two RNA tunnel inhibitors bind in highly conserved sites in dengue virus NS5 polymerase: structural and functional studies","volume":"94","author":"Arora","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105117","article-title":"Cinnamic acid inhibits Zika virus by inhibiting RdRp activity","volume":"192","author":"Chen","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2022.12.023_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijantimicag.2019.07.010","article-title":"Identification and characterization of Zika virus NS5 RNA-dependent RNA polymerase inhibitors","volume":"54","author":"Lin","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbrc.2022.12.023_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1055\/s-0033-1350672","article-title":"Structure-activity relationship study of biflavonoids on the dengue virus polymerase DENV-NS5 RdRp","volume":"79","author":"Coulerie","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.bbrc.2022.12.023_bib23","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1021\/acsomega.0c01364","article-title":"Sofosbuvir thio-analogues: synthesis and antiviral evaluation of the first novel pyridine- and pyrimidine-based thioglycoside phosphoramidates","volume":"5","author":"Abu-Zaied","year":"2020","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.bbrc.2022.12.023_bib24","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1128\/AAC.01253-16","article-title":"Antiviral nucleotide incorporation by recombinant human mitochondrial RNA polymerase is predictive of increased in\u00a0vivo mitochondrial toxicity risk","volume":"60","author":"Fenaux","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2022.12.023_bib25","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/AAC.04619-14","article-title":"In\u00a0vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis c virus polymerase inhibitor","volume":"59","author":"Kati","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2022.12.023_bib26","doi-asserted-by":"crossref","unstructured":"I. Gentile, F. Borgia, A. R. Buonomo, G. Castaldo, G. Borgia, A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir, Curr. Med. Chem. 20(30) 3733-3742. https:\/\/doi.org\/10.2174\/09298673113209990178.","DOI":"10.2174\/09298673113209990178"},{"key":"10.1016\/j.bbrc.2022.12.023_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.12832","article-title":"Development of sofosbuvir for the treatment of hepatitis C virus infection","volume":"1358","author":"Lawitz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2022.12.023_bib28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00081-16","article-title":"Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen","volume":"23","author":"Dos Santos Alves","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41998-1","article-title":"Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs","volume":"9","author":"S\u00e1ez-\u00c1lvarez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.12.023_bib30","article-title":"Polymerase activity, protein-protein interaction, and cellular localization of the Usutu virus NS5 protein","volume":"64","author":"Albentosa-Gonz\u00e1lez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2022.12.023_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004682","article-title":"A\u00a0crystal structure of the dengue virus NS5 protein reveals a novel inter-domain interface essential for protein flexibility and virus replication","volume":"11","author":"Zhao","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2022.12.023_bib32","doi-asserted-by":"crossref","first-page":"31105","DOI":"10.1074\/jbc.M113.508606","article-title":"A\u00a0crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities","volume":"288","author":"Lim","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.023_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14762","article-title":"Structure and function of the Zika virus full-length NS5 protein","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2022.12.023_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/viro.1998.9311","article-title":"Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus","volume":"249","author":"Lohmann","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2022.12.023_bib35","doi-asserted-by":"crossref","first-page":"33095","DOI":"10.1074\/jbc.M111.255034","article-title":"Full-length dengue virus RNA-dependent RNA polymerase-RNA\/DNA complexes","volume":"286","author":"Szymanski","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.023_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193133","article-title":"Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities","volume":"13","author":"Saisawang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.12.023_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003549","article-title":"Crystal structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface","volume":"9","author":"Lu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2022.12.023_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35511-3","article-title":"Identification of a small interface between the methyltransferase and RNA polymerase of NS5 that is essential for Zika virus replication","volume":"8","author":"Rusanov","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.12.023_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.12.023_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197867","article-title":"Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors","volume":"278","author":"de Albuquerque","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2022.12.023_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104574","article-title":"Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-na\u00efve subjects","volume":"170","author":"Han","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2022.12.023_bib42","article-title":"A\u00a0Phase 2 open label study of ledipasvir\/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection","author":"Price","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.bbrc.2022.12.023_bib43","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.dld.2016.07.014","article-title":"Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: impact of drug concentration on viral load decay","volume":"48","author":"Virlogeux","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib44","author":"El-Sayed"},{"key":"10.1016\/j.bbrc.2022.12.023_bib45","author":"Elmoety"},{"key":"10.1016\/j.bbrc.2022.12.023_bib46","author":"Chappell"},{"key":"10.1016\/j.bbrc.2022.12.023_bib47","first-page":"1","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.12.023_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01389-18","article-title":"Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","volume":"63","author":"Ferreira","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2022.12.023_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in\u00a0vitro and in\u00a0vivo","volume":"13","author":"de Freitas","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.bbrc.2022.12.023_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105274","article-title":"High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection","volume":"199","author":"Liang","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2022.12.023_bib51","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jac\/dkab072","article-title":"In\u00a0vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19","volume":"76","author":"Sacramento","year":"2021","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2022.12.023_bib52","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.12.023_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02729-22","article-title":"RNA-dependent RNA polymerase of the second human pegivirus exhibits a high-fidelity feature","author":"Chen","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2022.12.023_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35511-3","article-title":"Identification of a small interface between the methyltransferase and RNA polymerase of NS5 that is essential for Zika virus replication","volume":"8","author":"Rusanov","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.12.023_bib55","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1128\/JVI.73.9.7694-7702.1999","article-title":"A\u00a0recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA","volume":"73","author":"Oh","year":"1999","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.bbrc.2022.12.023_bib56","first-page":"1","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.bbrc.2022.12.023_bib57","doi-asserted-by":"crossref","first-page":"14645","DOI":"10.1021\/acsomega.0c01364","article-title":"Sofosbuvir thio-analogues: synthesis and antiviral evaluation of the first novel pyridine-and pyrimidine-based thioglycoside phosphoramidates","volume":"5","author":"Abu-Zaied","year":"2020","journal-title":"ACS Omega"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22016886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22016886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:24:43Z","timestamp":1757766283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22016886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":56,"alternative-id":["S0006291X22016886"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.29.498065","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir and its tri-phosphate metabolite inhibit the RNA-dependent RNA polymerase activity of non-structural protein 5 from the Kyasanur forest disease virus","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}